Paper · 42824914

ApoA2 isoforms as blood-based biomarkers reflecting pancreatic exocrine dysfunction for risk stratification and perioperative management of pancreatic cancer.

Matsushita A and 11 others. Front Oncol, 2026.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. ApoA2 isoforms as blood-based biomarkers reflecting pancreatic exocrine dysfunction for risk stratification and perioperative management of pancreatic cancer. Papers, record 42824914. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42824914

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: ApoA2 isoforms as blood-based biomarkers reflecting pancreatic exocrine dysfunction for risk stratification and perioperative management of pancreatic cancer.
Journal: Front Oncol
Year: 2026
Publication types: Journal Article, Review
PubMed: https://pubmed.ncbi.nlm.nih.gov/42824914/
DOI: https://doi.org/10.3389/fonc.2026.1902440
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC13628349/
The journal: https://conductscience.org/library/journal-index/101568867
Revised in PubMed: 2026-10-03

Source PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Matsushita A	Akira
2	Ono T	Takashi
3	Murokawa T	Takahiro
4	Ueda J	Junji
5	Shimizu T	Tetsuya
6	Kawano Y	Yoichi
7	Matsuda A	Akihisa
8	Hasegawa Y	Yuta
9	Itokawa N	Norio
10	Takeuchi K	Keiko

1 to 10 of 12Source PubMed

See all 12 authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	24,259,958	Diagnosis and treatment of diabetes mellitus in chronic pancreatitis.	World J Gastroenterol	2013	https://conductscience.org/library/papers/24259958	PubMed
2	39,639,485	European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence-based recommendations.	United European Gastroenterol J	2025	https://conductscience.org/library/papers/39639485	PubMed
3	28,701,476	Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers.	Sci Transl Med	2017	https://conductscience.org/library/papers/28701476	PubMed
4	28,404,095	Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.	Lancet Gastroenterol Hepatol	2016	https://conductscience.org/library/papers/28404095	PubMed
5	38,182,527	International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas.	Pancreatology	2024	https://conductscience.org/library/papers/38182527	PubMed
6	39,272,705	Potential of Carbohydrate Antigen 19-9 and Serum Apolipoprotein A2-Isoforms in the Diagnosis of Stage 0 and IA Pancreatic Cancer.	Diagnostics (Basel)	2024	https://conductscience.org/library/papers/39272705	PubMed
7	26,549,697	Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms.	Sci Rep	2015	https://conductscience.org/library/papers/26549697	PubMed
8	42,569,440	Monitoring with plasma apolipoprotein A2-isoforms can predict developing new-onset steatotic liver disease caused by pancreatic exocrine insufficiency following pancreatectomy.	Hepatobiliary Surg Nutr	2026	https://conductscience.org/library/papers/42569440	PubMed
9	36,093,581	Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis.	Int J Cancer	2023	https://conductscience.org/library/papers/36093581	PubMed
10	23,535,601	Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.	Nature	2013	https://conductscience.org/library/papers/23535601	PubMed

1 to 10 of 41

See all 41 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes
APOA2	336	PubTator's text mining	https://conductscience.org/library/genes/336

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42824914

GET https://conductscience.org/api/papers/v1/42824914/references?page=2

API reference For AI assistants